Lucid Diagnostics (LUCD) Cash & Current Investments (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Cash & Current Investments came in at $27.9 million in Q1 2026, up 10.45% YoY from $25.2 million in Q1 2025, and down 19.68% on a QoQ basis from $34.7 million in Q4 2025.
Lucid Diagnostics (LUCD) Cash & Current Investments (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Cash & Current Investments data on file, last reported at $27.9 million in Q1 2026.
- Quarterly Cash & Current Investments rose 10.45% year-over-year to $27.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.9 million (up 10.45% YoY) and the FY2025 annual result came in at $34.7 million, up 55.22% from the prior year.
- Cash & Current Investments retreated to $27.9 million in Q1 2026, from $34.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $47.9 million in Q1 2022 to a low of $14.5 million in Q3 2024.
- A 5-year average of $29.3 million and a median of $26.9 million in 2022 frame the typical range for Cash & Current Investments.
- The widest YoY moves for Cash & Current Investments: up 126137.35% in 2022, down 58.11% in 2022.
- Tracing LUCD's Cash & Current Investments over 5 years: stood at $22.5 million in 2022, then slipped by 15.92% to $18.9 million in 2023, then grew by 18.32% to $22.4 million in 2024, then jumped by 55.22% to $34.7 million in 2025, then declined by 19.68% to $27.9 million in 2026.
- The last three Cash & Current Investments figures came in at $27.9 million (Q1 2026), $34.7 million (Q4 2025), and $47.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 33.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.40 Mn |
| Mar 31, 2026 | 27.88 Mn |
| Dec 31, 2025 | 34.71 Mn |
| Sep 30, 2025 | 47.33 Mn |
| Jun 30, 2025 | 31.12 Mn |
| Mar 31, 2025 | 25.24 Mn |
| Dec 31, 2024 | 22.36 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 24.92 Mn |
| Mar 31, 2024 | 24.77 Mn |
| Dec 31, 2023 | 18.90 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 32.57 Mn |
| Mar 31, 2023 | 39.52 Mn |
| Dec 31, 2022 | 22.47 Mn |
| Sep 30, 2022 | 26.93 Mn |
| Jun 30, 2022 | 32.68 Mn |
| Mar 31, 2022 | 47.92 Mn |
| Dec 31, 2021 | 53.66 Mn |
| Sep 30, 2021 | 21,336.00 |